Cohen Joshua B 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Cohen Joshua B
DirectorCo-Chief Executive Officer
Transactions
- Sale
Common Stock
2025-03-03$3.17/sh−4,595$14,549→ 3,196,652 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.09 to $3.195. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.